Willow Biosciences Inc. WLLW.TO
0.04 0.00 (+0.00%)
Jun 20, 2025, 3:58 PM EDT
0.03 Day range 0.035
52-week range unavailable
- Market cap
- 7.93M
- Revenue (ttm)
- 1.84M
- Shares out
- 144.20M
- Forward P/E
- 2.75
- Volume
- 3.80M
- Open
- 0.03
- Previous close
- 0.035
- Day's range
- 0.03 – 0.035
- Beta
- 1.14
No chart data for this range yet.
Key statistics
- Enterprise value
- 14.39M
- PEG ratio
- 0.00
- Price / sales
- 4.31
- Price / book
- 1.96
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 660.00%
- Free cash flow
- -3.34M
- Total cash
- 1.02M
- Total debt
- 2.43M
- Return on equity
- -212.20%
- Short % of float
- 0.00%
- 50-day average
- 0.0838
- 200-day average
- 0.094025
Next earnings
Consensus EPS estimate 0.00.
About Willow Biosciences Inc.
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- willowbio.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on WLLW.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gilder, Gagnon, Howe & Co. | 0.35% | 430,433 | 23.67K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Spinnaker ETF Tr-Cannabis ETF | 2.35% | 2,912,070 | 160.16K | Feb 27, 2022 |